By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Food and Drug Administration late last month approved a Dako test for use as a companion diagnostic for determining which patients may benefit from treatment with Herceptin (trastuzumab).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.